Navigation Links
Tekni-Plex, Inc. Announces Expiration Of Change Of Control Offer To Purchase Its 9.750% Senior Secured Notes Due 2019
Date:1/13/2014

KING OF PRUSSIA, Pa., Jan. 13, 2014 /PRNewswire/ -- Tekni-Plex, Inc. (the "Company") today announced the expiration of its previously announced offer to purchase (the "Offer") any and all of its outstanding 9.750% senior secured notes due 2019 (the "Notes"). The Offer was made solely to fulfill the Company's obligations under the indenture governing the Notes following the consummation on December 13, 2013 of the previously announced merger (the "Merger") with an affiliate of American Securities LLC, which resulted in a "Change of Control" giving the holders of the Notes the right to require the Company to purchase all or a portion of such holders' Notes at a purchase price of 101% of the principal amount thereof, plus any accrued and unpaid interest up to, but not including, the date of purchase.

The Offer was commenced on December 13, 2013 and expired at 5:00 P.M., New York City Time, on Friday, January 10, 2014 (the "Expiration Date"). As of the Expiration Date, $74,000 in aggregate principal amount of the Notes (representing approximately 0.02% of the outstanding Notes) had been delivered for repurchase pursuant to the Offer.  Payment for the tendered notes will occur on January 15, 2014.

This press release shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes or any other securities.

About Tekni-Plex, Inc.

Tekni-Plex, Inc. is a global manufacturer of technically-sophisticated products and components engineered to meet critical customer needs in niche applications. The Company operates in three segments: Healthcare, Specialty Packaging and Food Packaging. Tekni-Plex's primary products include closure liners, medical tubing, high-barrier pharmaceutical films, medical compounds, dispensing components and thermoformed containers.   The Company is headquartered in King of Prussia, PA and operates 25 manufacturing facilities across nine countries worldwide to meet the needs of its global customers. For more information on the capabilities of Tekni-Plex, visit www.tekni-plex.com or call the Company at (484) 690-1520.

Contact:
Graham Sayers
Executive Vice President &
Chief Financial Officer
Graham.Sayers@Tekni-Plex.com


'/>"/>
SOURCE Tekni-Plex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tekni-Plex, Inc. To Hold Teleconference To Discuss Financial Results For Fiscal Year 2013 On September 12, 2013
2. Debiopharm Group Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty
3. Adaptive Announces a Biomarker Discovery Agreement with Johnson & Johnson Innovation
4. Medical Tracking Solutions, Inc. announces new client NovaBone Products, LLC
5. Volcano Corporation Announces Preliminary Fourth Quarter 2013 Revenues; Year-Over-Year Annual Revenues Increase Eight Percent On A Constant Currency Basis
6. Millennium Laboratories Announces Strategic Acquisition of RxAnte
7. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
8. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
9. Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile
10. Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
11. Mindray Announces Preliminary 2013 Operating Results and 2014 Net Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2017)... The Cincinnati location of ... (NYSE: DPLO), has been awarded a Top Workplaces 2017 ... Results are based on an employee survey administered by WorkplaceDynamics, ... improvement. The survey measures several aspects of workplace culture, including ... ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
(Date:6/1/2017)... BELL, Pa. , June 1, 2017 ... (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma ... investment in Nutriceutical Holdings by KD Pharma Group. KD ... Holdings with the option to acquire the entire company. ... partner in KD. They are committed to growing the ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. ... New York, has recently begun offering three new minimally invasive procedures to patients ... procedures and reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Goodcents Deli Fresh Subs today announced the opening ... 4210 SW 21st St. Topeka, Kan. 66604 (near 21st and Gage). It is owned ... owns three other locations in the Topeka and Bonner Springs, Kan. area. , ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... Breast Cancer Conference from Sept. 18 to 20. , The two-day conference is ... subtype with the goal of improving patients’ lives and eliminating racial breast cancer-related ...
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased to announce ... for CDA members. As part of the amalgam separator endorsement, all CDA members may ... than $400 off the retail value. This partnership between PureLife and CDA is especially ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
Breaking Medicine News(10 mins):